Aspira Women's Health Inc. (AWH): Price and Financial Metrics


Aspira Women's Health Inc. (AWH): $4.74

-0.14 (-2.87%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add AWH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 495

in industry

AWH POWR Grades


  • Stability is the dimension where AWH ranks best; there it ranks ahead of 43.59% of US stocks.
  • The strongest trend for AWH is in Momentum, which has been heading down over the past 122 days.
  • AWH's current lowest rank is in the Quality metric (where it is better than 5.19% of US stocks).

AWH Stock Summary

  • Aspira Women's Health Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 12.66% of US listed stocks.
  • AWH's price/sales ratio is 110.88; that's higher than the P/S ratio of 96.73% of US stocks.
  • With a year-over-year growth in debt of 295.02%, Aspira Women's Health Inc's debt growth rate surpasses 96.34% of about US stocks.
  • Stocks that are quantitatively similar to AWH, based on their financial statements, market capitalization, and price volatility, are IGC, DRQ, AMSC, SILK, and SREV.
  • AWH's SEC filings can be seen here. And to visit Aspira Women's Health Inc's official web site, go to www.vermillion.com.

AWH Valuation Summary

  • In comparison to the median Healthcare stock, AWH's price/sales ratio is 835.86% higher, now standing at 110.9.
  • AWH's price/earnings ratio has moved down 24.8 over the prior 243 months.
  • Over the past 243 months, AWH's price/earnings ratio has gone down 24.8.

Below are key valuation metrics over time for AWH.

Stock Date P/S P/B P/E EV/EBIT
AWH 2020-06-29 80.8 75.5 -26.3 -25.7
AWH 2019-10-07 10.1 2.8 -2.7 -1.6
AWH 2018-11-05 13.3 3.1 -3.1 -2.2
AWH 2015-07-14 26.7 5.6 -4.4 -3.5
AWH 2014-10-24 22.6 3.2 -4.2 -2.7
AWH 2011-10-25 20.2 1.7 -1.8 -0.4

AWH Growth Metrics

  • The year over year revenue growth rate now stands at -0.57%.
  • The 5 year price growth rate now stands at 21.91%.
  • Its year over year cash and equivalents growth rate is now at 630.07%.
AWH's revenue has moved up $1,998,000 over the prior 30 months.

The table below shows AWH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 4.927 -16.488 -20.119
2020-12-31 4.651 -14.734 -17.905
2020-09-30 4.513 -12.849 -15.211
2020-06-30 4.559 -13.224 -14.744
2020-03-31 4.955 -13.359 -15.227
2019-12-31 4.538 -12.966 -15.237

AWH Price Target

For more insight on analysts targets of AWH, see our AWH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.00 Average Broker Recommendation 1.25 (Strong Buy)

AWH Stock Price Chart Interactive Chart >

Price chart for AWH

AWH Price/Volume Stats

Current price $4.74 52-week high $10.54
Prev. close $4.88 52-week low $2.47
Day low $4.70 Volume 168,800
Day high $4.95 Avg. volume 638,548
50-day MA $5.43 Dividend yield N/A
200-day MA $5.81 Market Cap 530.62M

Aspira Women's Health Inc. (AWH) Company Bio


Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.


AWH Latest News Stream


Event/Time News Detail
Loading, please wait...

AWH Latest Social Stream


Loading social stream, please wait...

View Full AWH Social Stream

Latest AWH News From Around the Web

Below are the latest news stories about Aspira Women's Health Inc that investors may wish to consider to help them evaluate AWH as an investment opportunity.

Announcing: Aspira Women's Health (NASDAQ:AWH) Stock Soared An Exciting 649% In The Last Three Years

It hasn't been the best quarter for Aspira Women's Health Inc. ( NASDAQ:AWH ) shareholders, since the share price has...

Yahoo | July 21, 2021

Aspira Women's Health (AWH) is Oversold: Can It Recover?

Aspira Women's Health (AWH) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Yahoo | July 15, 2021

UPDATE -- Aspira Women’s Health Inc. Announces Coverage for OVA1® in the AIM Specialty Health Laboratory Medicine Clinical Guidelines

AIM is a member of the Anthem Blue Cross Blue Shield family of companies which promotes optimal care through use of evidence-based clinical guidelines and real-time decision support for both providers and their patients. AIM is a wholly owned subsidiary of Anthem, Inc., serving more than 50 million members across 50 states, D.C. and US territories. AUSTIN, Texas, July 08, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) today announced its OVA1® risk assessment test for ovarian

Yahoo | July 8, 2021

Aspira Women’s Health Inc. Announces Coverage for OVA1® in the AIM Specialty Health Laboratory Medicine Clinical Guidelines

AIM is a wholly owned subsidiary of Anthem, Inc., serving more than 50 million members across 50 states, D.C., and US territories.AUSTIN, Texas, July 08, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH) today announced its OVA1® risk assessment test for ovarian cancer in women with pelvic masses is considered medically necessary according to AIM Specialty Health’s Clinical Appropriateness Guidelines. AIM Specialty Health is a member of the Anthem Blue Cross Blue Shield family of

Yahoo | July 8, 2021

This Is Why We Think Aspira Women's Health Inc.'s (NASDAQ:AWH) CEO Might Get A Pay Rise Approved By Shareholders

Shareholders will be pleased by the robust performance of Aspira Women's Health Inc. ( NASDAQ:AWH ) recently and this...

Yahoo | June 15, 2021

Read More 'AWH' Stories Here

AWH Price Returns

1-mo -18.84%
3-mo -21.00%
6-mo -39.15%
1-year 13.40%
3-year 702.03%
5-year 248.53%
YTD -29.36%
2020 728.40%
2019 170.00%
2018 -84.46%
2017 103.16%
2016 -47.22%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9303 seconds.